The First Affiliated Hospital of Xiamen University
🇨🇳China
A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2022-03-18
- Target Recruit Count
- 20
- Registration Number
- NCT05287386
- Locations
- 🇨🇳
the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC
Phase 2
Active, not recruiting
- Conditions
- Non-small Cell Lung Cancer Stage IV
- Interventions
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2021-09-24
- Target Recruit Count
- 20
- Registration Number
- NCT05055167
- Locations
- 🇨🇳
First affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Prevention In Community Clinics From Diabetic Kidney Disease
Not Applicable
Not yet recruiting
- Conditions
- Diabetic Nephropathies
- Interventions
- Other: Intensively integrated care of microvascular risk factors in the intervention group
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2021-08-03
- Target Recruit Count
- 1240
- Registration Number
- NCT04988581
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
Not Applicable
Completed
- Conditions
- Tumor, Solid, FAPI, PET/CT, Metastasis
- Interventions
- Diagnostic Test: 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2023-08-08
- Target Recruit Count
- 7
- Registration Number
- NCT04941872
- Locations
- 🇨🇳
The First affiliated hospital of xiamen university, Xiamen, Fujian, China
68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)
Phase 1
- Conditions
- 177Lu-DOTA-FAPI68Ga-DOTA-FAPITheranostic
- Interventions
- Drug: 68Ga-DOTA-FAPI, 177Lu-DOTA-FAPI
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2021-04-19
- Target Recruit Count
- 30
- Registration Number
- NCT04849247
- Locations
- 🇨🇳
First affiliated hospital of xiamen university, XiaMen, Fujian, China
Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer
Phase 1
- Conditions
- Multiple Primary Lung Cancer
- Interventions
- Radiation: Stereotactic Ablation Radiotherapy
- First Posted Date
- 2021-04-12
- Last Posted Date
- 2021-04-12
- Target Recruit Count
- 39
- Registration Number
- NCT04840758
Diabetic Complications and Obstructive Sleep Apnea
Recruiting
- Conditions
- Diabetic Complications and Obstructive Sleep Apnea
- Interventions
- Other: regular treatment
- First Posted Date
- 2020-11-30
- Last Posted Date
- 2023-08-22
- Target Recruit Count
- 330
- Registration Number
- NCT04646941
- Locations
- 🇨🇳
The first affiliated hospital of Xiamen university, Xiamen, Fujian, China
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
Not Applicable
Completed
- Conditions
- Lung AdenocarcinomaPET/CT68Ga-FAPI18F-FDG
- Interventions
- Diagnostic Test: 68Ga-FAPI PET/CT scan
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2025-01-29
- Target Recruit Count
- 63
- Registration Number
- NCT04588064
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer
Phase 1
- Conditions
- Locally Advanced or Metastatic Gastric Adenocarcinoma
- Interventions
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2020-10-01
- Target Recruit Count
- 46
- Registration Number
- NCT04572542
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer
Not Applicable
- Conditions
- NSCLCBiopsyGenomicsWhole-exome SequencingPET/CTRadiomics
- Interventions
- Diagnostic Test: 18F-FDG PET/CT and PET/CT-guide targeted biopsy in another group of participants
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2020-09-17
- Target Recruit Count
- 150
- Registration Number
- NCT04553601
- Locations
- 🇨🇳
First affiliated hospital of xiamen university, XiaMen, Fujian, China
© Copyright 2025. All Rights Reserved by MedPath